Youcare Pharmaceutical Group Co., Ltd. logo

Youcare Pharmaceutical Group Co., Ltd. (688658)

Market Closed
10 Aug, 06:57
SSE SSE
¥
13. 16
-0.06
-0.4539%
¥
6.96B Market Cap
- P/E Ratio
0.8% Div Yield
15.03M Volume
- Eps
¥ 13.22
Previous Close
Add Transaction
Day Range
13.1 13.8
Year Range
11.29 35.57
Want to track 688658 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688658 closed yesterday lower at ¥13.16, a decrease of -0.4539% from Friday's close, completing a monthly increase of 3.2157% or ¥0.41. Over the past 12 months, 688658 stock lost -41.3024%.
688658 is not paying dividends to its shareholders.
The last earnings report, released on May 22, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

688658 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Youcare Pharmaceutical Group Co., Ltd. (688658) FAQ

What is the stock price today?

The current price is ¥13.16.

On which exchange is it traded?

Youcare Pharmaceutical Group Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688658.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, the market cap is 6.96B.

Has Youcare Pharmaceutical Group Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Youcare Pharmaceutical Group Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Fei Yu CEO
SSE Exchange
CNE100005XQ2 ISIN
CN Country
3,179 Employees
25 Jun 2024 Last Dividend
- Last Split
- IPO Date

Overview

Youcare Pharmaceutical Group Co., Ltd., established in 1988 and headquartered in Beijing, China, is a prominent entity in the pharmaceutical industry. The company is deeply involved in the research and development, manufacture, distribution, and sale of a wide range of pharmaceutical products. With its dedication to enhancing healthcare solutions, Youcare has solidified its reputation for delivering quality and effective pharmaceutical preparations across multiple therapeutic areas.

Products and Services

Youcare Pharmaceutical Group Co., Ltd. provides a diversified portfolio of pharmaceutical products, catering to a broad spectrum of healthcare needs. The products are formulated in various forms to suit different patient preferences and treatment requirements, such as:

  • Injection: Sterile solutions designed for administration via intravenous, intramuscular, or subcutaneous routes, offering rapid absorption and effective treatment for critical care situations.
  • Tablets: Solid dosage forms that are convenient for oral administration, aiding in various treatments ranging from chronic to acute medical conditions.
  • Capsules: Gelatin or plant-based shells filled with medications in powder or liquid form, providing a user-friendly option for oral administration.
  • Granules: Small, coarse particles offering a versatile option for oral consumption either directly or after dissolving in water, catering to patients who may find swallowing tablets or capsules challenging.

Beyond these forms, the company addresses an array of therapeutic categories including:

  • Antibiotics: Medications to combat bacterial infections, crucial for treating infections in various parts of the body.
  • Gastrointestinal: Treatments designed to alleviate disorders of the digestive tract, ensuring better digestion and relief from gastrointestinal discomforts.
  • External: Preparations for topical administration, aimed at treating conditions affecting the skin or for external pain relief.
  • Hypoglycemic: Drugs that help in managing blood sugar levels, critical for patients managing diabetes.
  • Antibacterial and Antiviral Agent: Compounds designed to fight off viral and bacterial pathogens, providing immunity and treatment for infectious diseases.
  • Anti-hepatitis: Medications specifically formulated to combat hepatitis virus, promoting liver health and function.
  • Anti-tumor: Oncology drugs targeted at preventing the growth of tumors, playing a key role in cancer treatment and management.
  • Cardio-cerebral: Medicines focused on heart and brain health, contributing to the treatment of cardiovascular and cerebrovascular diseases.
  • Immunomodulation: Agents that help in modulating the immune system, either by enhancing or suppressing it to fight against diseases, including autoimmune disorders.

Contact Information

Address: No.6 Middle Hongda Road, Beijing, China, 100176
Phone: 86 10 6780 6688